sGC is the target of the earliest class of cardiovascular drugs known, nitroglycerin and other NO precursors, which have been used since the 19th Century as vasodilators to alleviate angina, myocardial infarction and other disorders [2,5]. Here, SGCB is linked to angina pectoris.